Semnur Reseach Site 62 — Overland Park, Kansas

Semnur Reseach Site 62 is a clinical research site located in Overland Park, Kansas, United States 66210.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Semnur Reseach Site 62 has participated in 1 clinical trials.

Therapeutic areas: Lumbosacral Radicular Pain.

Sponsors: Scilex Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Semnur Reseach Site 62?

Semnur Reseach Site 62 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Semnur Reseach Site 62 conducted?

Semnur Reseach Site 62 has 1 clinical trials on record. Their work covers Lumbosacral Radicular Pain.

Is Semnur Reseach Site 62 accredited by Crixeo Health?

Semnur Reseach Site 62 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Semnur Reseach Site 62?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.